Published in J Pain Symptom Manage on March 22, 2013
Response to "safety profile of intravenous patient-controlled analgesia for breathrough pain in cancer patients: a case series study". Support Care Cancer (2014) 1.07
Breakthrough pain and its treatment: critical review and recommendations of IOPS (Italian Oncologic Pain Survey) expert group. Support Care Cancer (2015) 0.85
Breakthrough cancer pain: a comparison of surveys with European and Canadian patients. Support Care Cancer (2014) 0.83
A Korean Nationwide Survey for Breakthrough Cancer Pain in an Inpatient Setting. Cancer Res Treat (2015) 0.78
Canadian recommendations for the management of breakthrough cancer pain. Curr Oncol (2016) 0.77
Pharmacologic management of adult breakthrough cancer pain. Can Fam Physician (2014) 0.76
Consensus and controversies in the definition, assessment, treatment and monitoring of BTcP: results of a Delphi study. Clin Transl Oncol (2016) 0.75
Reply-Letter to the Editor: What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion. Drugs (2016) 0.75
Breakthrough pain in patients with controlled or uncontrolled basal pain: an observational study. Pain Res Manag (2014) 0.75
A fixed inhaled nitrous oxide/oxygen mixture as an analgesic for adult cancer patients with breakthrough pain: study protocol for a randomized controlled trial. Trials (2017) 0.75
Breakthrough cancer pain and rational drug use. Support Care Cancer (2017) 0.75
A new focus on breakthrough cancer pain: commentary on Davies et al. J Pain Symptom Manage (2013) 0.75
Definition and classification of cancer cachexia: an international consensus. Lancet Oncol (2011) 7.78
Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney Int (2003) 3.95
Studies comparing Numerical Rating Scales, Verbal Rating Scales, and Visual Analogue Scales for assessment of pain intensity in adults: a systematic literature review. J Pain Symptom Manage (2011) 3.44
Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol (2012) 3.26
Prognostic factors in advanced cancer patients: evidence-based clinical recommendations--a study by the Steering Committee of the European Association for Palliative Care. J Clin Oncol (2005) 2.76
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy. Kidney Int (2011) 2.52
The management of cancer-related breakthrough pain: recommendations of a task group of the Science Committee of the Association for Palliative Medicine of Great Britain and Ireland. Eur J Pain (2008) 2.48
European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med (2009) 2.46
Dual blockade of the renin-angiotensin system in type 1 patients with diabetic nephropathy. Nephrol Dial Transplant (2002) 2.41
Which domains should be included in a cancer pain classification system? Analyses of longitudinal data. Pain (2012) 2.07
Ultrasound-guided rectus sheath block for pyloromyotomy in infants: a retrospective analysis of a case series. Paediatr Anaesth (2013) 2.04
Palliative Care of Adult Patients With Cancer. Dtsch Arztebl Int (2015) 2.02
Episodic (breakthrough) pain: consensus conference of an expert working group of the European Association for Palliative Care. Cancer (2002) 2.01
The Total Neuropathy Score as an assessment tool for grading the course of chemotherapy-induced peripheral neurotoxicity: comparison with the National Cancer Institute-Common Toxicity Scale. J Peripher Nerv Syst (2007) 2.01
Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage (2002) 1.91
White paper defining optimal palliative care in older people with dementia: a Delphi study and recommendations from the European Association for Palliative Care. Palliat Med (2013) 1.87
Assessment and classification of cancer breakthrough pain: a systematic literature review. Pain (2010) 1.70
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol (2005) 1.69
Pain assessment tools: is the content appropriate for use in palliative care? J Pain Symptom Manage (2006) 1.61
Current knowledge of buprenorphine and its unique pharmacological profile. Pain Pract (2010) 1.53
Drugs in palliative care: results from a representative survey in Germany. Palliat Med (2004) 1.50
Breakthrough cancer pain. BMJ (2008) 1.46
Update on cancer pain guidelines. J Pain Symptom Manage (2009) 1.46
What are the problems in palliative care? Results from a representative survey. Support Care Cancer (2003) 1.45
Assessment of quality of life in patients receiving palliative care: comparison of measurement tools and single item on subjective well-being. J Palliat Med (2011) 1.43
Effect of mesocaval shunt on survival of small-for-size liver grafts: experimental study in pigs. Transplantation (2003) 1.43
High dose levo-methadone treatment for cancer pain in a patient with a history of drug addiction. J Pain Symptom Manage (2008) 1.41
[Models of care, organization and quality improvement for the care of advanced and terminal patients and their families: the contribution of palliative care]. Med Clin (Barc) (2010) 1.38
How should I know? Researching attitudes and practices around hastening death. Palliat Med (2010) 1.37
Reduction of atherosclerosis by the peroxisome proliferator-activated receptor alpha agonist fenofibrate in mice. J Biol Chem (2002) 1.36
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer. Cancer Immunol Immunother (2010) 1.26
Symptomatic and neurophysiological responses of paclitaxel- or cisplatin-induced neuropathy to oral acetyl-L-carnitine. Eur J Cancer (2005) 1.25
Use of complementary/alternative medicine among paediatric patients. Eur J Pediatr (2003) 1.24
The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC Public Health (2013) 1.22
Prevalence and aetiology of neuropathic pain in cancer patients: a systematic review. Pain (2011) 1.22
Electronic pain diary: a randomized crossover study. J Pain Symptom Manage (2004) 1.22
The Role of BCL2 Family of Apoptosis Regulator Proteins in Acute and Chronic Leukemias. Adv Hematol (2011) 1.20
Urinary connective tissue growth factor excretion correlates with clinical markers of renal disease in a large population of type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2006) 1.20
Implementing the cross-disciplinary subject of palliative medicine (Q13) against the backdrop of recent changes of the legal framework using University Medical School Göttingen as an example. GMS Z Med Ausbild (2010) 1.20
Differential palliative care issues in patients with primary and secondary brain tumours. Support Care Cancer (2009) 1.18
Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain (2005) 1.17
What is palliative care in Germany? Results from a representative survey. J Pain Symptom Manage (2002) 1.17
Pharmacological treatments for fatigue associated with palliative care. Cochrane Database Syst Rev (2010) 1.17
Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation. Arterioscler Thromb Vasc Biol (2004) 1.16
Resource consumption and costs of palliative care services in Spain: a multicenter prospective study. J Pain Symptom Manage (2006) 1.15
Validation and clinical application of the german version of the palliative care outcome scale. J Pain Symptom Manage (2005) 1.14
The Budapest Commitments: setting the goals a joint initiative by the European Association for Palliative Care, the International Association for Hospice and Palliative Care and Help the Hospices. Palliat Med (2007) 1.14
Knowledge and attitude of final - year medical students in Germany towards palliative care - an interinstitutional questionnaire-based study. BMC Palliat Care (2011) 1.13
Fatigue in palliative care patients -- an EAPC approach. Palliat Med (2008) 1.12
Conversion ratios for opioid switching in the treatment of cancer pain: a systematic review. Palliat Med (2011) 1.10
CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. Clin Cancer Res (2007) 1.10
Evolving classification systems for cancer cachexia: ready for clinical practice? Support Care Cancer (2010) 1.10
The Catalonia World Health Organization demonstration project for palliative care implementation: quantitative and qualitative results at 20 years. J Pain Symptom Manage (2012) 1.10
Opioid-induced mast cell activation and vascular responses is not mediated by mu-opioid receptors: an in vivo microdialysis study in human skin. Anesth Analg (2004) 1.07
Symptom assessment in palliative care: a need for international collaboration. J Clin Oncol (2008) 1.07
Modelling the landscape of palliative care for people with dementia: a European mixed methods study. BMC Palliat Care (2013) 1.05
Enriched enrolment with randomised withdrawal (EERW): Time for a new look at clinical trial design in chronic pain. Pain (2008) 1.04
Additive effect of ACE inhibition and angiotensin II receptor blockade in type I diabetic patients with diabetic nephropathy. J Am Soc Nephrol (2003) 1.04
Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes (2010) 1.03
Multi-centre European study of breakthrough cancer pain: pain characteristics and patient perceptions of current and potential management strategies. Eur J Pain (2011) 1.03
[For a coordination of the supportive care for people affected by severe illnesses: proposition of organization in the public and private health care centres]. Bull Cancer (2004) 1.03
Axillary brachial plexus block for treatment of severe forearm ischemia after arterial cannulation in an extremely low birth-weight infant. Paediatr Anaesth (2004) 1.02
Validation of the Symptom and Problem Checklist of the German Hospice and Palliative Care Evaluation (HOPE). J Pain Symptom Manage (2011) 1.02
Attitudes of health care professionals, relatives of advanced cancer patients and public towards euthanasia and physician assisted suicide. Health Policy (2010) 1.02
Issues and needs in end-of-life decision making: an international modified Delphi study. Palliat Med (2011) 1.02
[Quality assurance in palliative medicine--results of the core documentation of 1999-2002]. Z Arztl Fortbild Qualitatssich (2005) 1.02
Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin (2005) 1.01
Midazolam does not reduce emergence delirium after sevoflurane anesthesia in children. Paediatr Anaesth (2007) 1.00
Driving ability under long-term treatment with transdermal fentanyl. J Pain Symptom Manage (2003) 1.00
Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study. Clin Ther (2005) 1.00
Non-cancer patients in specialized palliative care in Germany: what are the problems? Palliat Med (2010) 1.00
Episodic (breakthrough) pain prevalence in a population of cancer pain patients. Comparison of clinical diagnoses with the QUDEI--Italian questionnaire for intense episodic pain. J Pain Symptom Manage (2012) 0.99
Bone morphogenetic protein 4 expression in multiple normal and tumor tissues reveals its importance beyond development. Mod Pathol (2012) 0.99
Undergraduate training in palliative medicine in Germany: what effect does a curriculum without compulsory palliative care have on medical students' knowledge, skills and attitudes? Palliat Med (2007) 0.99
Docetaxel versus docetaxel plus cisplatin as front-line treatment of patients with advanced non-small-cell lung cancer: a randomized, multicenter phase III trial. J Clin Oncol (2004) 0.98
Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int (2002) 0.98
Palliative care research--priorities and the way forward. Eur J Cancer (2008) 0.98